Background: This study was conducted to determine the prevalence of metabolic syndrome and oxidative stress among type 2 diabetes mellitus (DM) patients in Enugu metropolis. Materials and Methods: Two hundred and forty participants aged 40-80 years attending Diabetic Clinic, University of Nigeria Teaching Hospital, Nigeria with their age and gender-marched healthy individuals were recruited as subjects and controls respectively, and evaluated for metabolic syndrome using the National Cholesterol Education Programme-Adult Treatment Panel III criteria. Oxidative stress markers were assayed spectrophotometrically. Results: Prevalence of metabolic syndrome was found to be 56% among type 2 DM patients (55% for males and 58% for females), and 15% among apparently healthy individuals. Besides raised fasting blood glucose in the subjects, the second abnormal parameter was raised blood pressure (86%), followed by low high-density lipoproteins (45%), central obesity (33%), and raised fasting triglycerides (17%) in that particular order. Furthermore, oxidative stress markers were found to have changed significantly in subjects when compared to controls: Malondialdehyde values and superoxide dismutase activities were significantly higher while ascorbic acid values were significantly lower. Conclusion: It can be concluded from this study that metabolic syndrome and disturbances of reduction-oxidation homeostasis are common among type 2 DM patients.
Published in | Central African Journal of Public Health (Volume 8, Issue 2) |
DOI | 10.11648/j.cajph.20220802.12 |
Page(s) | 28-32 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Metabolic Syndrome, Oxidative Stress, Type 2 Diabetes
[1] | Lemieux I, Després JP. Metabolic Syndrome: Past, Present and Future. Nutrients. 2020; 12 (11): 3501. |
[2] | National Cholesterol Education Programme – Adult Treatment Panel III. Executive summary of the third report of the National Cholesterol Education Programme (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2012; 285: 2486-2497. |
[3] | Bovolini A, Garcia J, Andrade MA, Duarte JA. Metabolic Syndrome Pathophysiology and Predisposing Factors. Int J Sports Med. 2021; 42 (3): 199-214. |
[4] | Korac B, Kalezic A, Pekovic-Vaughan V, Korac A, Jankovic A. Redox changes in obesity, metabolic syndrome, and diabetes. Redox Biology. 2021; 42: 101887. |
[5] | Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci. 2020; 21 (17): 6275. |
[6] | Mizukami H, Kudoh K. Diversity of pathophysiology in type 2 diabetes shown by islet pathology. J Diabetes Investig. 2022; 13 (1): 6-13. |
[7] | Araoye MO. Research methodology with statistics for health and social sciences. Nathadex. 2004; 115-121. |
[8] | Measurement of blood pressure. Cardiovascular system. In: Swash, M. and Glynn M. (Editors). Hutchison’s Clinical Methods, 22nd Edition. Edinburgh: Saunders, 2007. |
[9] | Powel-Tuck J. Waist and waist-hip ratio. Nutritional assessment. In: Swash, M. and Glynnnd (Editors) Edn. Edinburgh: Saunders, 2007. Hutchison’s Clinical Methods. |
[10] | Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969; 22 (2): 158-161. |
[11] | Buccolo G, David H. Quantitative determination of serum triglycerides by use of enzymes. Clin Chem 1973; 19 (5): 476-482. |
[12] | Burstein M, Scholnick HR, Morfix R. Rapid method for the isolation of lipoproteins from 25 human serum by precipitation with polyanions. J Lipid Res 1970; 11 (6): 583-595. |
[13] | McCord JM, Fridovich I. Superoxide Dismutase: an enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969; 244: 6049-6055. |
[14] | Pearson D. The Chemical Analysis of Food. 17th Edition. London: Churchill Livingstone 1976. |
[15] | Wallin B, Kosengreen B, Shertner HG, Camejo G. Lipoprotein oxidation and measurement 35 of TRARS formation in a single microlitre plate: Its use for evaluation of antioxidants. Anal Biochem 1993; 208 (1): 10-15. |
[16] | Osuji CU, Nzerem BA, Dioka CE, Onwubuya EI. Metabolic syndrome in newly diagnosed type 2 diabetes mellitus using NCEP – ATP III. The Nnewi experience. Niger J Clin Pract 2012, 15 (4): 475-80. |
[17] | Nwegbu MM, Jaiyesimi OO. Prevalence of metabolic syndrome amongst apparently healthy Nigerian adults in a hospital setting. J Med Med Sci 2012; 3 (1): 7782–7783. |
[18] | Adebisi SA, Oghagbon EK. Prevalence of obesity among diabetics in Ilorin, Middle belt of Nigeria. Sahel Med J 2003; 6 (4): 112-115. |
[19] | Alebiosu CO, Odusan BO. Metabolic syndrome in subjects with type 2 diabetes mellitus. J Natl Med Assoc 2004; 96: 617-821. |
[20] | Isezuo SA, Ezunu E. Demographic and clinical correlates of metabolic syndrome in native African type 2 diabetic patients. J Natl Med Assoc 2005, 97 (4): 557-63. |
[21] | Avinash-Tejasvi ML, Bangi BA, Geetha P, Anulekha-Avinash CK, Chittaranjan B, Bhayya H, Donempudi P. Estimation of serum superoxide dismutase and serum malondialdehyde in oral submucous fibrosis: A clinical and biochemical study. J Can Res Ther 2014; 10 (3): 722-725. |
[22] | Dadheech G, Mishra S, Gautam S, Sharma P. Oxidative stress, α-tocopherol, ascorbic acid and reduced glutathione status in schizophrenics. Indian J Clin Biochem 2006; 21 (2): 348. |
[23] | Sturtz LA, Diekert K, Jensen LT, Lill R, Cullotta VC. A fraction of yeast Cu, Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage. J Biol Chem 2001; 276 (41): 38084-9. |
APA Style
Ezra Agbo, Victor Ogugua, Innocent Okagu, Collins Amadi, Aloysius Aleke. (2022). Metabolic Syndrome and Oxidative Stress Among Patients of Type 2 Diabetes in an African Community. Central African Journal of Public Health, 8(2), 28-32. https://doi.org/10.11648/j.cajph.20220802.12
ACS Style
Ezra Agbo; Victor Ogugua; Innocent Okagu; Collins Amadi; Aloysius Aleke. Metabolic Syndrome and Oxidative Stress Among Patients of Type 2 Diabetes in an African Community. Cent. Afr. J. Public Health 2022, 8(2), 28-32. doi: 10.11648/j.cajph.20220802.12
AMA Style
Ezra Agbo, Victor Ogugua, Innocent Okagu, Collins Amadi, Aloysius Aleke. Metabolic Syndrome and Oxidative Stress Among Patients of Type 2 Diabetes in an African Community. Cent Afr J Public Health. 2022;8(2):28-32. doi: 10.11648/j.cajph.20220802.12
@article{10.11648/j.cajph.20220802.12, author = {Ezra Agbo and Victor Ogugua and Innocent Okagu and Collins Amadi and Aloysius Aleke}, title = {Metabolic Syndrome and Oxidative Stress Among Patients of Type 2 Diabetes in an African Community}, journal = {Central African Journal of Public Health}, volume = {8}, number = {2}, pages = {28-32}, doi = {10.11648/j.cajph.20220802.12}, url = {https://doi.org/10.11648/j.cajph.20220802.12}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cajph.20220802.12}, abstract = {Background: This study was conducted to determine the prevalence of metabolic syndrome and oxidative stress among type 2 diabetes mellitus (DM) patients in Enugu metropolis. Materials and Methods: Two hundred and forty participants aged 40-80 years attending Diabetic Clinic, University of Nigeria Teaching Hospital, Nigeria with their age and gender-marched healthy individuals were recruited as subjects and controls respectively, and evaluated for metabolic syndrome using the National Cholesterol Education Programme-Adult Treatment Panel III criteria. Oxidative stress markers were assayed spectrophotometrically. Results: Prevalence of metabolic syndrome was found to be 56% among type 2 DM patients (55% for males and 58% for females), and 15% among apparently healthy individuals. Besides raised fasting blood glucose in the subjects, the second abnormal parameter was raised blood pressure (86%), followed by low high-density lipoproteins (45%), central obesity (33%), and raised fasting triglycerides (17%) in that particular order. Furthermore, oxidative stress markers were found to have changed significantly in subjects when compared to controls: Malondialdehyde values and superoxide dismutase activities were significantly higher while ascorbic acid values were significantly lower. Conclusion: It can be concluded from this study that metabolic syndrome and disturbances of reduction-oxidation homeostasis are common among type 2 DM patients.}, year = {2022} }
TY - JOUR T1 - Metabolic Syndrome and Oxidative Stress Among Patients of Type 2 Diabetes in an African Community AU - Ezra Agbo AU - Victor Ogugua AU - Innocent Okagu AU - Collins Amadi AU - Aloysius Aleke Y1 - 2022/03/11 PY - 2022 N1 - https://doi.org/10.11648/j.cajph.20220802.12 DO - 10.11648/j.cajph.20220802.12 T2 - Central African Journal of Public Health JF - Central African Journal of Public Health JO - Central African Journal of Public Health SP - 28 EP - 32 PB - Science Publishing Group SN - 2575-5781 UR - https://doi.org/10.11648/j.cajph.20220802.12 AB - Background: This study was conducted to determine the prevalence of metabolic syndrome and oxidative stress among type 2 diabetes mellitus (DM) patients in Enugu metropolis. Materials and Methods: Two hundred and forty participants aged 40-80 years attending Diabetic Clinic, University of Nigeria Teaching Hospital, Nigeria with their age and gender-marched healthy individuals were recruited as subjects and controls respectively, and evaluated for metabolic syndrome using the National Cholesterol Education Programme-Adult Treatment Panel III criteria. Oxidative stress markers were assayed spectrophotometrically. Results: Prevalence of metabolic syndrome was found to be 56% among type 2 DM patients (55% for males and 58% for females), and 15% among apparently healthy individuals. Besides raised fasting blood glucose in the subjects, the second abnormal parameter was raised blood pressure (86%), followed by low high-density lipoproteins (45%), central obesity (33%), and raised fasting triglycerides (17%) in that particular order. Furthermore, oxidative stress markers were found to have changed significantly in subjects when compared to controls: Malondialdehyde values and superoxide dismutase activities were significantly higher while ascorbic acid values were significantly lower. Conclusion: It can be concluded from this study that metabolic syndrome and disturbances of reduction-oxidation homeostasis are common among type 2 DM patients. VL - 8 IS - 2 ER -